Colloidal gold-based nanoparticles have been designed to target the delivery of tumor necrosis factor (TNF) and paclitaxel to solid tumors, introducing AuNPs as tumor-targeted drug delivery vectors (Paciotti et al., 2006). This evidence concerns the gene TNF and neoplasm.